GoalVest Advisory’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.1K Buy
208
+6
+3% +$2.54K 0.02% 170
2026
Q1
$95.6K Hold
202
0.02% 178
2025
Q4
$94.3K Hold
202
0.02% 190
2025
Q3
$86.1K Hold
202
0.02% 181
2025
Q2
$77.4K Sell
202
-3
-1% -$1.08K 0.02% 182
2025
Q1
$70.8K Sell
205
-75
-27% -$24.1K 0.02% 160
2024
Q4
$84K Hold
280
0.02% 156
2024
Q3
$114K Hold
280
0.03% 135
2024
Q2
$90K Sell
280
-115
-29% -$37.4K 0.03% 138
2024
Q1
$132K Buy
395
+180
+84% +$55K 0.04% 135
2023
Q4
$58.2K Buy
215
+109
+103% +$26.9K 0.03% 126
2023
Q3
$26.1K Buy
+106
New +$29K 0.01% 192
2022
Q3
Sell
-105
Closed -$18K 276
2022
Q2
$18K Hold
105
0.01% 226
2022
Q1
$26K Buy
+105
New +$26.4K 0.01% 179

Other funds holding HCA

GoalVest Advisory's HCA Position: Q2 2026 in Review

GoalVest Advisory increased its HCA Healthcare (HCA) stake by 3% in Q2 2026, buying an estimated $2.54K and bringing the position to 208 shares worth $81.1K. The position accounts for 0.02% of the portfolio, ranked #170.

GoalVest Advisory first reported a position in HCA in Q1 2022 and has held it in 14 quarters since. The position peaked at $132K in Q1 2024. 185 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • GoalVest Advisory held 208 shares of HCA Healthcare worth $81.1K as of Q2 2026.
  • GoalVest Advisory bought 6 HCA Healthcare shares in Q2 2026, an estimated $2.54K.
  • HCA Healthcare made up 0.02% of GoalVest Advisory's portfolio in Q2 2026, its #170 holding.
  • GoalVest Advisory first reported a position in HCA Healthcare in Q1 2022 and has held it in 14 quarters since.
  • GoalVest Advisory's HCA Healthcare position peaked at $132K in Q1 2024.
  • 185 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on GoalVest Advisory's 13F filing for Q2 2026, filed 9 Jul 2026.